Annual EBIT
-$299.00 M
-$35.00 M-13.26%
31 December 2023
Summary:
Arcus Biosciences annual earnings before interest & taxes is currently -$299.00 million, with the most recent change of -$35.00 million (-13.26%) on 31 December 2023. During the last 3 years, it has fallen by -$176.00 million (-143.09%). RCUS annual EBIT is now -643.64% below its all-time high of $59.00 million.RCUS EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$91.00 M
+$2.00 M+2.15%
30 September 2024
Summary:
Arcus Biosciences quarterly earnings before interest & taxes is currently -$91.00 million, with the most recent change of +$2.00 million (+2.15%) on 30 September 2024. Over the past year, it has dropped by -$23.00 million (-33.82%). RCUS quarterly EBIT is now -132.32% below its all-time high of $281.54 million, reached on 31 December 2021.RCUS Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$267.00 M
-$23.00 M-9.43%
30 September 2024
Summary:
Arcus Biosciences TTM earnings before interest & taxes is currently -$267.00 million, with the most recent change of -$23.00 million (-9.43%) on 30 September 2024. Over the past year, it has increased by +$18.00 million (+6.32%). RCUS TTM EBIT is now -419.62% below its all-time high of $83.54 million, reached on 30 September 2022.RCUS TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RCUS EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -13.3% | -33.8% | +6.3% |
| 3 y3 years | -143.1% | -16.7% | +3.7% |
| 5 y5 years | -445.0% | -291.4% | -215.4% |
RCUS EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -643.6% | at low | -132.3% | +2.1% | -419.6% | +10.7% |
| 5 y | 5 years | -643.6% | at low | -132.3% | +2.1% | -419.6% | +10.7% |
| alltime | all time | -643.6% | at low | -132.3% | +2.1% | -419.6% | +10.7% |
Arcus Biosciences EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$91.00 M(-2.2%) | -$267.00 M(+9.4%) |
| June 2024 | - | -$93.00 M(+3000.0%) | -$244.00 M(+8.4%) |
| Mar 2024 | - | -$3.00 M(-96.3%) | -$225.00 M(-24.7%) |
| Dec 2023 | -$299.00 M(+13.3%) | -$80.00 M(+17.6%) | -$299.00 M(+4.9%) |
| Sept 2023 | - | -$68.00 M(-8.1%) | -$285.00 M(+1.1%) |
| June 2023 | - | -$74.00 M(-3.9%) | -$282.00 M(+2.9%) |
| Mar 2023 | - | -$77.00 M(+16.7%) | -$274.00 M(+3.8%) |
| Dec 2022 | -$264.00 M(-580.0%) | -$66.00 M(+1.5%) | -$264.00 M(-416.0%) |
| Sept 2022 | - | -$65.00 M(-1.5%) | $83.54 M(+18.4%) |
| June 2022 | - | -$66.00 M(-1.5%) | $70.56 M(+16.5%) |
| Mar 2022 | - | -$67.00 M(-123.8%) | $60.59 M(+10.2%) |
| Dec 2021 | $55.00 M(-144.7%) | $281.54 M(-461.1%) | $55.00 M(-119.8%) |
| Sept 2021 | - | -$77.97 M(+2.6%) | -$277.31 M(+40.2%) |
| June 2021 | - | -$75.97 M(+4.7%) | -$197.79 M(+18.3%) |
| Mar 2021 | - | -$72.59 M(+43.0%) | -$167.19 M(+35.9%) |
| Dec 2020 | -$123.00 M | -$50.78 M(-3371.7%) | -$123.00 M(+43.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2020 | - | $1.55 M(-103.4%) | -$85.75 M(-22.4%) |
| June 2020 | - | -$45.38 M(+59.8%) | -$110.55 M(+17.2%) |
| Mar 2020 | - | -$28.40 M(+109.9%) | -$94.34 M(+11.4%) |
| Dec 2019 | -$84.71 M(+54.4%) | -$13.53 M(-41.8%) | -$84.71 M(+0.1%) |
| Sept 2019 | - | -$23.25 M(-20.3%) | -$84.67 M(+15.1%) |
| June 2019 | - | -$29.16 M(+55.3%) | -$73.56 M(+22.0%) |
| Mar 2019 | - | -$18.77 M(+39.2%) | -$60.30 M(+9.9%) |
| Dec 2018 | -$54.86 M(+2.7%) | -$13.48 M(+11.0%) | -$54.86 M(+0.3%) |
| Sept 2018 | - | -$12.14 M(-23.6%) | -$54.72 M(-16.7%) |
| June 2018 | - | -$15.90 M(+19.3%) | -$65.71 M(+10.5%) |
| Mar 2018 | - | -$13.33 M(-0.1%) | -$59.47 M(+11.3%) |
| Dec 2017 | -$53.44 M(+193.9%) | -$13.34 M(-42.3%) | -$53.44 M(+33.3%) |
| Sept 2017 | - | -$23.13 M(+139.4%) | -$40.10 M(+136.4%) |
| June 2017 | - | -$9.66 M(+32.4%) | -$16.96 M(+132.4%) |
| Mar 2017 | - | -$7.30 M | -$7.30 M |
| Dec 2016 | -$18.18 M | - | - |
FAQ
- What is Arcus Biosciences annual earnings before interest & taxes?
- What is the all time high annual EBIT for Arcus Biosciences?
- What is Arcus Biosciences annual EBIT year-on-year change?
- What is Arcus Biosciences quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Arcus Biosciences?
- What is Arcus Biosciences quarterly EBIT year-on-year change?
- What is Arcus Biosciences TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Arcus Biosciences?
- What is Arcus Biosciences TTM EBIT year-on-year change?
What is Arcus Biosciences annual earnings before interest & taxes?
The current annual EBIT of RCUS is -$299.00 M
What is the all time high annual EBIT for Arcus Biosciences?
Arcus Biosciences all-time high annual earnings before interest & taxes is $59.00 M
What is Arcus Biosciences annual EBIT year-on-year change?
Over the past year, RCUS annual earnings before interest & taxes has changed by -$35.00 M (-13.26%)
What is Arcus Biosciences quarterly earnings before interest & taxes?
The current quarterly EBIT of RCUS is -$91.00 M
What is the all time high quarterly EBIT for Arcus Biosciences?
Arcus Biosciences all-time high quarterly earnings before interest & taxes is $281.54 M
What is Arcus Biosciences quarterly EBIT year-on-year change?
Over the past year, RCUS quarterly earnings before interest & taxes has changed by -$23.00 M (-33.82%)
What is Arcus Biosciences TTM earnings before interest & taxes?
The current TTM EBIT of RCUS is -$267.00 M
What is the all time high TTM EBIT for Arcus Biosciences?
Arcus Biosciences all-time high TTM earnings before interest & taxes is $83.54 M
What is Arcus Biosciences TTM EBIT year-on-year change?
Over the past year, RCUS TTM earnings before interest & taxes has changed by +$18.00 M (+6.32%)